# Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (Text with EEA relevance), Article 64: Modification of authorised investigational medicinal products

Extent: E+W+S+N.I.

Articles 61, 62 and 63 shall apply to authorised investigational medicinal products only as regards any modification of such products not covered by a marketing authorisation.

---
Source: https://www.legislation.gov.uk/eur/2014/536/article/64 (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-536/article-64
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

